Clinical trial

A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced…

NCT00000978 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00000978
Title A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)
Official title An Open-Label, Randomized, Dose-Finding, Multicenter Trial of Dideoxycytidine (ddC) Administered Concurrently With Zidovudine (AZT) in the Treatment of AIDS or Advanced ARC
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Hoffmann-La Roche Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Zidovudine, Zalcitabine
Enrollment 68
First posted Aug 31, 2001
Last update posted Aug 8, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies